Clarus director awarded 20,000 stock options
Clarus Corp director Mark Besca received a grant of stock options covering 20,000 shares of common stock.
Rhea-AI Filing Summary
Clarus Corp director Mark Besca received a grant of stock options covering 20,000 shares of common stock. The options were awarded at an exercise price of $3.11 per share and were granted at no upfront cost. They expire on May 28, 2036 and were issued under the company’s Amended and Restated 2015 Stock Incentive Plan.
According to the vesting schedule, options for 5,000 shares will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. After this grant, Besca holds options to purchase 20,000 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to purchase) | 20,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The option to purchase shares of Clarus Corporation's (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan. Options to purchase 5,000 shares of the Issuer's Common Stock will vest and become exercisable on each of June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, respectively.
Key Figures
Key Terms
Stock Option (right to purchase) financial
Amended and Restated 2015 Stock Incentive Plan financial
vesting financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Clarus Corp (CLAR) director Mark Besca report in this Form 4?
What is the exercise price and expiration date of Mark Besca’s Clarus (CLAR) options?
How do Mark Besca’s Clarus Corp (CLAR) stock options vest over time?
Is Mark Besca’s Clarus (CLAR) Form 4 transaction an open-market buy or sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.